SMARCB1 and cancer: After depletion of DCAF5, SMARCB1-deficient SWI/SNF complexes reaccumulate, bind to target loci, and restore SWI/SNF-mediated gene expression to levels that are sufficient to reverse the cancer state, including in vivo [45].